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Hyperglycemia with and without glycosuria on inulin and para-amino
hippurate clearance. The response of the clearances of inulin (Ci,,) and
para-amino hippurate (CPAH) to acute hyperglycemia with and without
glycosuna was investigated in ten, healthy non-diabetic subjects. Stan-
dard methodology (UV/P) was used, with a mean clearance calculated
from three, 15-minute urine collection periods. Each subject was
studied at three levels of blood glucose (mmol!liter) concentration,
mean (SE): Level 1, fasting, 4.5 (0.1); Level 2, hyperglycemia below
renal threshold for glucose, 7.2 (0.1); Level 3, hyperglycemia with
glycosuria, 12.6 (0.5). There was a significant rise in mean Cm (ml!
min/l.73 m2) when changing from Level 1(112 [3]) to Level 2 (121 [5]),
with no further increase on changing to Level 3 (122 [4]). With
glycosuna Cm fell in some subjects. Mean CPAH (mI/min/! .73 m2)
increased through Level 1 (560 [27]) to Level 3 (603 [34]), with
consequently no change in mean filtration fraction at the three levels of
glycemia. Our observations show a rise in glomerular filtration rate with
mild hyperglycemia below renal threshold, with no futher increase
during hyperglycemia sufficient to produce glycosuria.
A raised glomerular filtration rate (GFR) has been reported in
a proportion of subjects with type 1 insulin-dependent diabetes
mellitus (IDDM) [1—8]. Hyperfiltration has been suggested as an
early patho-physiological change in the development of diabetic
nephropathy [9—11] and as a predictor of the development of
chronic renal failure [12]. Although several possible metabolic
abnormalities of IDDM have been suggested as a cause of
hyperfiltration [10], persistent hyperglycemia is the most likely
factor to induce a rise in GFR. The effect of a raised blood
glucose concentration on GFR and renal plasma flow (RPF) has
been investigated previously in both diabetic and non-diabetic
subjects [13—21]. These studies however, indicated a variable
response of renal hemodynamics to acute glycemia. Study
design and methodological differences appear to account for the
lack of consistency in these observations, with blood glucose
concentration fluctuating throughout the clearance periods in
several studies, and no account taken in any study on the effect
of the appearance of glycosuria. We therefore investigated in
healthy non-diabetic subjects the effect of short term hypergly-
cemia, with and without glycosuria, on inulin and para-amino
hippurate (PAH) clearances, with blood glucose being held
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constant at a known concentration during the clearance collec-
tion periods.
Methods
We studied ten healthy, non-diabetic volunteer subjects (9
male, 1 female; age range 23 to 47 yr; surface area range 1.69 to
1.95 m2). Approval for the study was given by the Guy's
Hospital Ethical committee.
Following an overnight fast two cannula were inserted in
opposite arms (one for sampling, one for infusion). The clear-
ances of inulin (C1) and PAH (CPAH) were measured by
standard methodology (UV/P). Following an intravenous bolus
injection (equilibration time 60 mins) and infusion of inulin
(Polyfructosan, mutest, SAS Pharmaceuticals Ltd, London,
UK) and PAH (Merck, Sharp and Dohme, Hoddesdon, UK) the
clearance was calculated from the mean of three timed (approx-
imately 15 mins) urine collection periods. A diuresis (>10
ml/min) was maintained throughout the study by drinking
water. Nine out of 85 urine collections were rejected because of
a sudden decrease in urine flow rate indicating incomplete
bladder emptying. Blood samples were taken at the midpoint of
each period.
C1, and CPAH were measured at three different blood glucose
concentrations; Level 1, fasting blood glucose; Level 2, hyper-
glycemia without glycosuria; Level 3, hyperglycemia with
glycosuria. The raised blood glucose concentrations were main-
tained at a steady level throughout the clearance periods by a
modification of the hyperglycemic clamp technique [22]. A
dextrose (20%) infusion rate was adjusted to venous blood
glucose concentration (mmollliter) sampled every five minutes
at the bedside (YSI 23AM glucose analyzer, Clandon Scientific,
Aldershot, UK). Target values for the blood glucose concen-
trations were: Level 1, 4 mmollliter; Level 2, 7.5 mmollliter;
Level 3, 12 mmol/liter. One clearance period from Level 2 was
rejected because of glycosuria.
Plasma and urine inulin were determined following perchloric
acid hydrolysis of the inulin to fructose, which was measured
enzymatically on a centrifugal analyzer (Cobas Bio, Roche
Diagnostica, Welwyn Garden City, UK), using sorbitol dehy-
drogenase (Sigma Chemical Co., Poole, UK)[23]. Samples from
each subject were analyzed in batches. Intra-assay coefficients
of variation for plasma and urine inulin were 1.8% and 1.3%,
respectively. Plasma and urine PAH were measured using the
method of Brun [24], adapted for use on the centrifugal ana-
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lyzer. PAH was measured on acid hydrolyzed urine samples
because of our observations of a reaction between PAH and
glucose in urine, even during storage at —20°C [25], Samples for
analysis were prepared by adding 10 pi of concentrated hydro-
chloric acid to 200 d of urine, mixing and incubating for 10
minutes at 70°C. Intra-assay coefficients of variation for plasma
and urine PAH using the Brun method were 1.7% and 0.9%,
respectively. Urine glucose was measured on the centrifugal
analyser using a hexokinase method (BCL, Lewes, UK).
Changes between each level were compared statistically
using a paired Student's t-test, with significance taken as P <
0.05, with the effect of multiplicity adjusted for by the Bonfer-
roni correction factor [261. Results are expressed as mean (SE)
and range.
Results
Blood glucose (mmol/liter) was significantly different at each
clearance period; Level 1, 4.5 (3.9 to 5.0); Level 2, 7.2 (6.5 to
8.4), Level 3, 12.6 (9.3 to 14.9); P < 0.001. Glycosuria was
present only in Level 3 with a urine glucose concentration of
25.4 (13.9) mmol/liter.
The urine flow (mi/mm) was similar during each blood glu-
cose level: Level 1, 15.5 (0.6); Level 2, 15.0(0.6), Level 3, 16.4
(1.3). Urine osmolality (mOsmol/liter) increased during
glycosuria Level 1, 71.6 (3.4); Level 2,62.5(3.0); Level 3, 101.0
(14.4).
Mean C,, (ml/min/1.73 m2) increased from Level 1(112 [4.0])
to Level 2 (120 [4.0]); t = 2.64, P = 0.013 (one tailed). It rose in
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Table I. Inulin (Ci,.) and para aminohippurate (CPAH) clearance (ml!
mm/I .73 m2) at different blood glucose concentration (mmol/liter)
Subject C1,, CPAH
Blood
glucose
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Mean (SE)
105
131
113
112
103
107
105
109
109
127
112 (3.0)
452
620
438
636
506
507
548
619
562
709
560 (27)
4.4
3.9
4.4
4.6
5.0
4.5
4.7
4.1
4.2
4.5
4.5 (0.1)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Mean (SE)
128
141
119
112
106
112
112
100
130
152
121 (5.2)
514
685
418
652
472
557
571
597
673
673
581 (29)
6.9
7.5
7.5
7.6
7.2
6,5
6.5
8.4
6.9
7.3
7.2 (0.1)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Mean (SE)
129
130
108
137
115
116
111
108
127
136
122 (3.6)
561
594
435
682
522
558
592
842
638
609
603 (34)
14.3
9.3
12.7
11.8
11.9
13.1
10.6
14.9
12.9
14.0
12.6 (0.5)
eight out of ten subjects, with one subject showing no change.
No further rise in mean C1,, was seen in changing to Level 3 (122
[4.0]); t = 0.13, P = 0.45. (Fig. 1 and Table 1). Level ito Level
3was significantly different, t = 2.92, P = 0.009; however three
subjects had a fall in Cm from Level 2 to 3. Mean CPAH
(mI/mm/i .73 m2) increased from Level 1 (560 [27]) compared
with Level 2(581 [29]), t = 1.36,P 0.10) and Level 3 (603 [33],
t = 1.61, P 0.07). Plasma inulin and PAH concentrations were
constant during each level of glycemia. Calculation of the mean
ifitration fraction (CIfl/CpAH) produced identical values for each
of the three different levels of glycemia (0.22 [0.1]) (Table 1,
Fig. 1).
Discussion
We Observed a rise in C with an increase in blood glucose
without glycosuria. With the onset of glycosuria mean Cm
showed no change. Previous studies have reported varying
changes in GFR in response to acute hyperglycemia. In both
diabetic and normal subjects GFR was unaffected following a
moderate rise in blood glucose (4.4 to 9.8 mmol/liter) by means
of an oral glucose load [16], and following a bolus of i.v. glucose
[3, iS], whereas intravenous glucose infusion resulting in higher
blood glucose values (>10 mmol/liter) produced an increase in
GFR [14, 16—18]. No change GFR was noted at blood glucose
concentrations sufficient to calculate the maximum rate of
glucose reabsorption [13]. Brochner-Mortensen suggested that
there was a threshold effect in terms of glycemia on GFR, with
no increase in GFR if blood glucose concentration remained
below 7.8 mmollliter [17]. Our data suggests that this is not the
case. With the onset of glycosuna the mean C1,, remained
elevated, but showed no further increase from the elevation of
GFR induced when increasing blood glucose from 4.5 to 7.2
mmollliter. In fact, three out of the ten subjects had a fall in C,
with the onset of the osmotic diuresis consequent upon the
glycosuria.
Experimental design probably accounts for the reported
inconsistencies in the changes of GFR with hyperglycemia. In
normal subjects the blood glucose concentration fluctuates
following a bolus or simple infusion of oral or intravenous
glucose, secondary to increased insulin secretion. It is probable
that in many of the studies several of the clearances were
measured at normal glucose concentration. To obtain a sus-
tained period of hyperglycemia by bolus or simple infusion of
glucose, it would be necessary to give a large dose certainly
sufficient to raise blood glucose above renal threshold. None of
the studies comment on the relation of GFR to glycosuria.
Using this unique study design with the glucose clamp tech-
nique, we were able to hold the glucose concentration at the
desired level, thereby observing the relation of GFR to hyper-
glycemia with and without glycosuria.
The response of effective renal plasma flow (RPF) to hyper-
glycemia differs in several studies, with reports of an increase
[3, 18, 191, a decrease [211 and no change [20] in diabetic adults,
with no change reported in non-diabetic subjects [18, 201.
However in all of these studies no account was taken of blood
glucose concentration or the presence of glycosuna at the time
of the measurement of RPF. Those studies in which PAH was
used to calculate RPF may have suffered from an artefact
caused by the reaction between PAH and glucose in the urine
[25]. In our study calculation of mean CPAH using acid hydro-
lyzed urine, which reconverts any PAH that has been glycosyl-
ated, showed a continuing rise from normoglycemia through the
two glycemic levels. Although with the small number of sub-
jects this increase in CPAH was not statistically significant, the
ifitration fractions in the three Levels were identical. This
suggests that renal blood flow rises with the increase in GFR,
and may be the effector mechanism of hyperfiltration due to
hyperglycemia.
This study shows that short-term mild hyperglycemia even
below renal threshold induces a rise in Cm. A maintenance of a
constant filtration fraction even in the face of glycosuria sug-
gests a rise in RPF as the effector mechanism of the rise in GFR.
The hyperfiltration of diabetes mellitus may therefore be in-
duced with an increase in the level of blood glucose concentra-
tion, which is within physiological limits and is seen even in
non-diabetic subjects following a carbohydrate containing meal.
Daily profiles in diabetic subjects show that there is a consid-
erable variation in blood glucose concentratiOn with periods of
glycosuria. Thus, it is likely that the GFR fluctuates consider-
ably throughout the day in the average diabetic, and even in the
most poorly controlled subject may not remain elevated given
the effect of glycosuria. The relevance of intermittent increases
of GFR in diabetes to the long term complication of nephrop-
athy remains unclear. The level of blood glucose and the
Level
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presence of urine glucose should be taken into account in the
interpretation of GFR and RPF in diabetes mellitus.
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